New Validation and Clinical Outcome Data From Several Studies on Nanosphere, Inc.'s Gram-Positive and Gram-Negative Blood Culture Tests to be Presented at American Society for Microbiology 2013
5/17/2013 10:47:00 AM
More...
|
Nanosphere, Inc. Announces Distribution and Collaboration Agreement With Hitachi High-Technologies Corporation
5/14/2013 10:26:55 AM
More...
|
Nanosphere, Inc. to Release First Quarter 2013 Results and Hold Investor Conference Call on Wednesday, May 8, 2013
4/30/2013 12:11:10 PM
More...
|
Nanosphere, Inc. Welcomes Ken Bahk, Ph.D. as Chief Strategy Officer and Announces Other Organizational Changes
4/26/2013 9:43:28 AM
More...
|
Nanosphere, Inc. Receives CE Mark for BC-GN Test
3/13/2013 7:09:30 AM
More...
|
Nanosphere, Inc. to Present at the Cowen and Company 33rd Annual Health Care Conference
2/22/2013 9:30:25 AM
More...
|
Nanosphere, Inc. Announces Record Revenues and Placements, and Key Leadership Changes
2/14/2013 9:19:12 AM
More...
|
Nanosphere, Inc. Receives FDA Clearance for C. Difficile Test
12/11/2012 7:03:24 AM
More...
|
Nanosphere, Inc. Receives FDA Clearance for Verigene CYP2C19 Test
11/13/2012 6:56:25 AM
More...
|
Nanosphere, Inc. Announces Third Quarter 2012 Results
11/8/2012 9:50:14 AM
More...
|
|